Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Cerilliant
Argus Health
McKinsey
Citi
Johnson and Johnson
Colorcon
US Department of Justice
Mallinckrodt

Generated: July 17, 2018

DrugPatentWatch Database Preview

Sermorelin acetate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for sermorelin acetate and what is the scope of sermorelin acetate freedom to operate?

Sermorelin acetate
is the generic ingredient in one branded drug marketed by Emd Serono and Emd Serono Inc, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for sermorelin acetate.
Summary for sermorelin acetate
US Patents:0
Tradenames:1
Applicants:2
NDAs:2
Drug Master File Entries: 1
Bulk Api Vendors: 22
Patent Applications: 517
DailyMed Link:sermorelin acetate at DailyMed
Synonyms for sermorelin acetate
00IBG87IQW
114466-38-5
114466-38-5 (acetate)
168S787
68S787
8259AH
86168-78-7
86168-78-7 (Parent)
89243S03TE
ACETIC ACID; SERMORELIN
AKOS025311435
AM006908
AN-33322
BDBM50004966
C149H246N44O42S.C2H4O2
Geref
GHRH (1-29);Growth Hormone Releasing Factor Fragment 1-29 amide human
Growth Hormone Releasing Factor Fragment 1-29 amide human
Growth Hormone Releasing Factor Fragment 1-29 amide human, >=97% (HPLC)
Growth hormone-releasing factor (human)-(1-29)-peptide amide, acetate (salt), hydrate
LS-186521
LS-187357
SCHEMBL34139
Sermelin Acetate
SERMORELIN
Sermorelin [INN:BAN]
Sermorelin acetate [USAN]
Sermorelina [Spanish]
Sermoreline [French]
Sermorelinum [Latin]
Somatoliberin
Somatoliberin (human pancreatic islet), 29-L-argininamide-30-de-L-glutamine-31-de-L-glutamine-32-deglycine-33-de-L-glutamic acid-34-de-L-serine-35-de-L-asparagine-36-de-L-glutamine-37-de-L-glutamic acid-38-de-L-arginine-39-de
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg(GRF(1-29)-NH2)
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-D-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg(D-Asn8,(1-29)-NH2)
Tyr-Ala-D-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg(D-Asp3,(1-29)-NH2)
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg(D-Ala2(1-29)-NH2)
UNII-00IBG87IQW
UNII-89243S03TE

US Patents and Regulatory Information for sermorelin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emd Serono Inc GEREF sermorelin acetate INJECTABLE;INJECTION 020443-001 Sep 26, 1997 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Emd Serono GEREF sermorelin acetate INJECTABLE;INJECTION 019863-001 Dec 28, 1990 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Emd Serono Inc GEREF sermorelin acetate INJECTABLE;INJECTION 020443-002 Sep 26, 1997 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for sermorelin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Emd Serono Inc GEREF sermorelin acetate INJECTABLE;INJECTION 020443-002 Sep 26, 1997 ➤ Sign Up ➤ Sign Up
Emd Serono Inc GEREF sermorelin acetate INJECTABLE;INJECTION 020443-002 Sep 26, 1997 ➤ Sign Up ➤ Sign Up
Emd Serono GEREF sermorelin acetate INJECTABLE;INJECTION 019863-001 Dec 28, 1990 ➤ Sign Up ➤ Sign Up
Emd Serono Inc GEREF sermorelin acetate INJECTABLE;INJECTION 020443-001 Sep 26, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Medtronic
Cantor Fitzgerald
Colorcon
Moodys
Healthtrust
Express Scripts
McKinsey
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.